[Pubmed] Factors Influencing Quality of Life in Myasthenia Gravis Patients: Results From a Cross-Sectional Study in Sout
-
RSS-Bot
Auteur du sujet - Ami(e) de Diamant

- Messages : 6511
- Enregistré le : 31 mai 2020 09:57
- 6
- Zodiaque :
- Âge : 22
- Contact :
[Pubmed] Factors Influencing Quality of Life in Myasthenia Gravis Patients: Results From a Cross-Sectional Study in Sout
Brain Behav. 2025 Aug;15(8):e70680. doi: 10.1002/brb3.70680.
ABSTRACT
BACKGROUND: Myasthenia gravis (MG) is an autoimmune disorder of the neuromuscular junction characterized by fatigue and muscle weakness, often leading to significant impairments in quality of life (QOL). This single-center cross-sectional study investigated factors influencing QOL among MG patients.
METHODS: Fifty-two participants diagnosed with MG were assessed using the MG Foundation of America (MGFA) classification and the MG composite (MGC) scale for disease severity. Patients completed validated questionnaires, including the Fatigue Severity Scale (FSS), Beck Depression Inventory (BDI), MG Activities of Daily Living (MG-ADL), and the MG Quality of Life 15-item scale (MG-QOL). Family stress levels were self-reported and categorized as "Rarely/Never," "Sometimes," "Often," or "Always."
RESULTS: The analysis revealed no significant differences in QOL scores based on sex, disease type, presenting symptoms, thymectomy status, or BMI. Employed or freelance patients exhibited significantly lower QOL and higher fatigue compared to retired or housewife groups. Higher family stress correlated with increased fatigue, worse MGC scores, and poorer QOL. Regression analysis identified the MG-ADL and FSS scores as the strongest predictors of QOL.
CONCLUSION: QOL in MG is influenced by complex interactions among functional, social, and occupational factors. These findings emphasize the need for tailored interventions to address fatigue and support occupational and familial well-being in MG patients. Further research with larger cohorts is warranted to refine these insights and guide clinical strategies.
PMID:40842108 | DOI:10.1002/brb3.70680
Source: https://pubmed.ncbi.nlm.nih.gov/4084210 ... t9+e462414
Si vous appréciez notre travail, merci de nous soutenir un petit don en cliquant ICI
Pour obtenir la traduction en français,
cliquez sur le bouton situé dans la barre des menus en haut de cette page

Pour les donateurs, si cet article vous intéresse, nous pouvons faire l’acquisition d'un tiré-à-part.
Merci d'en faire la demande sur [email protected]
Bonne lecture...
Pour obtenir la traduction en français,
cliquez sur le bouton situé dans la barre des menus en haut de cette page

Pour les donateurs, si cet article vous intéresse, nous pouvons faire l’acquisition d'un tiré-à-part.
Merci d'en faire la demande sur [email protected]
Bonne lecture...





